Argent BioPharma Limited
RGTLF
$0.0599
$0.011423.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 444.60K | 498.10K | 469.00K | 458.30K | 4.42M |
| Total Receivables | 212.10K | 237.60K | 317.90K | 310.70K | 362.20K |
| Inventory | 203.60K | 228.10K | 583.90K | 570.70K | 837.40K |
| Prepaid Expenses | 405.40K | 454.20K | 457.50K | 447.20K | 768.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.27M | 1.42M | 1.83M | 1.79M | 6.39M |
|
|
|||||
| Total Current Assets | 1.27M | 1.42M | 1.83M | 1.79M | 6.39M |
| Net Property, Plant & Equipment | 627.30K | 702.80K | 4.48M | 4.38M | 4.54M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00 | 0.00 | -- | -- | -- |
| Total Assets | 1.89M | 2.12M | 7.20M | 7.03M | 11.82M |
|
|
|||||
| Total Accounts Payable | 2.83M | 3.17M | 638.40K | 623.90K | 1.69M |
| Total Accrued Expenses | -- | -- | 231.40K | 226.10K | -- |
| Short-term Debt | 5.19M | 5.81M | 5.79M | 5.66M | 6.26M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 148.00K | 165.80K | 149.30K | 145.90K | 105.10K |
| Total Finance Division Other Current Liabilities | -- | -- | 1.31M | 1.28M | 410.90K |
| Total Other Current Liabilities | -- | -- | 1.31M | 1.28M | 410.90K |
| Total Current Liabilities | 8.16M | 9.14M | 8.12M | 7.94M | 8.46M |
|
|
|||||
| Total Current Liabilities | 8.16M | 9.14M | 8.12M | 7.94M | 8.46M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 5.19M | 5.81M | 5.79M | 5.66M | 6.26M |
| Capital Leases | 454.00K | 508.60K | 547.70K | 535.30K | 213.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.80K | 12.10K | 2.41M | 2.36M | 2.69M |
| Total Liabilities | 8.63M | 9.67M | 11.08M | 10.83M | 11.36M |
|
|
|||||
| Common Stock & APIC | 80.19M | 89.84M | 82.26M | 80.40M | 81.01M |
| Retained Earnings | -87.77M | -98.34M | -86.51M | -84.56M | -86.06M |
| Treasury Stock & Other | 849.70K | 951.90K | 818.90K | 800.40K | 5.97M |
| Total Common Equity | -6.73M | -7.54M | -3.44M | -3.36M | 924.20K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.73M | -7.54M | -3.44M | -3.36M | 924.20K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -448.60K | -438.50K | -466.30K |
| Total Equity | -6.73M | -7.54M | -3.89M | -3.80M | 457.90K |
|
|
|||||